Precision A3G base editors for disease modeling and correction
Authors:
- 14 January 2026
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 34 (4) , 2343-2360
Abstract
No abstract availableKeywords
Funding Information
- National Science Foundation (CBET-2143626)
- Cystic Fibrosis Foundation (DGE-2236662)
- Cystic Fibrosis Foundation (BAO19XX1)
- Cystic Fibrosis Foundation (BAO19XX0)
- National Institutes of Health (HL169761)
- National Institutes of Health (HL173243)
- National Institutes of Health (T32NS091006)
- National Heart, Lung, and Blood Institute (HL157714)
This publication has 45 references indexed in Scilit:
- Cystic fibrosis cell models for high-throughput analysis and drug screeningJournal of Cystic Fibrosis, 2024
- International disparities in diagnosis and treatment access for cystic fibrosisPediatric Pulmonology, 2024
- In vitro modulator responsiveness of 655 CFTR variants found in people with cystic fibrosisJournal of Cystic Fibrosis, 2024
- Cystic FibrosisJAMA, 2023
- Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical studyJournal of Cystic Fibrosis, 2023
- Worldwide rates of diagnosis and effective treatment for cystic fibrosisJournal of Cystic Fibrosis, 2022
- Imagine CRISPR curesMolecular Therapy, 2021
- Invited review: human air-liquid-interface organotypic airway tissue models derived from primary tracheobronchial epithelial cells—overview and perspectivesIn Vitro Cellular & Developmental Biology - Animal, 2020
- Isogenic cell models of cystic fibrosis-causing variants in natively expressing pulmonary epithelial cellsJournal of Cystic Fibrosis, 2019
- Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosisCell, 1990